Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans
Abstract Apolipoprotein B to A-1 (apo B/A-1) ratio is reportedly a better predictor of atherosclerotic vascular disease than low-density lipoprotein cholesterol (LDL-C). The aim of this study was to assess the association of serum apo B/A-1 ratio with insulin resistance and adiponectin in patients w...
Saved in:
Published in | Metabolism, clinical and experimental Vol. 59; no. 5; pp. 677 - 682 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.05.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Apolipoprotein B to A-1 (apo B/A-1) ratio is reportedly a better predictor of atherosclerotic vascular disease than low-density lipoprotein cholesterol (LDL-C). The aim of this study was to assess the association of serum apo B/A-1 ratio with insulin resistance and adiponectin in patients with different grades of glucose intolerance. Patients were divided according to glucose tolerance into 3 groups: normal glucose tolerance without metabolic syndrome (n = 229), impaired fasting glucose (subjects with fasting plasma glucose level between 100 and 125 mg/dL, n = 658), and type 2 diabetes mellitus (n = 381). Serum concentrations of apo B, apo A-1, glucose, total cholesterol (TC), triglycerides, and high-density lipoprotein cholesterol (HDL-C) and adiponectin were measured. Insulin resistance was estimated by the homeostasis model assessment of insulin resistance index (HOMA-IR). There were significant differences in metabolic parameters among the groups, including waist circumference, insulin, HOMA-IR, and apo B/A-1 ratio, which increased sequentially with glucose intolerance, whereas adiponectin level decreased with increasing severity of glucose intolerance. The apo B/A-1 ratio was significantly correlated with TC, triglycerides, LDL-C, HDL-C, adiponectin, and HOMA-IR in normal glucose tolerance, impaired fasting glucose, and type 2 diabetes mellitus. Multiple regression analysis showed that apo B/A-1 ratio was significantly associated with TC, LDL-C, HDL-C, and adiponectin. In conclusion, apo B/A-1 ratio was significantly associated with insulin resistance according to glucose intolerance; and serum adiponectin was an important independent factor associated with apo B/A-1 ratio in Koreans. |
---|---|
AbstractList | Abstract Apolipoprotein B to A-1 (apo B/A-1) ratio is reportedly a better predictor of atherosclerotic vascular disease than low-density lipoprotein cholesterol (LDL-C). The aim of this study was to assess the association of serum apo B/A-1 ratio with insulin resistance and adiponectin in patients with different grades of glucose intolerance. Patients were divided according to glucose tolerance into 3 groups: normal glucose tolerance without metabolic syndrome (n = 229), impaired fasting glucose (subjects with fasting plasma glucose level between 100 and 125 mg/dL, n = 658), and type 2 diabetes mellitus (n = 381). Serum concentrations of apo B, apo A-1, glucose, total cholesterol (TC), triglycerides, and high-density lipoprotein cholesterol (HDL-C) and adiponectin were measured. Insulin resistance was estimated by the homeostasis model assessment of insulin resistance index (HOMA-IR). There were significant differences in metabolic parameters among the groups, including waist circumference, insulin, HOMA-IR, and apo B/A-1 ratio, which increased sequentially with glucose intolerance, whereas adiponectin level decreased with increasing severity of glucose intolerance. The apo B/A-1 ratio was significantly correlated with TC, triglycerides, LDL-C, HDL-C, adiponectin, and HOMA-IR in normal glucose tolerance, impaired fasting glucose, and type 2 diabetes mellitus. Multiple regression analysis showed that apo B/A-1 ratio was significantly associated with TC, LDL-C, HDL-C, and adiponectin. In conclusion, apo B/A-1 ratio was significantly associated with insulin resistance according to glucose intolerance; and serum adiponectin was an important independent factor associated with apo B/A-1 ratio in Koreans. Apolipoprotein B to A-1 (apo B/A-1) ratio is reportedly a better predictor of atherosclerotic vascular disease than low-density lipoprotein cholesterol (LDL-C). The aim of this study was to assess the association of serum apo B/A-1 ratio with insulin resistance and adiponectin in patients with different grades of glucose intolerance. Patients were divided according to glucose tolerance into 3 groups: normal glucose tolerance without metabolic syndrome (n = 229), impaired fasting glucose (subjects with fasting plasma glucose level between 100 and 125 mg/dL, n = 658), and type 2 diabetes mellitus (n = 381). Serum concentrations of apo B, apo A-1, glucose, total cholesterol (TC), triglycerides, and high-density lipoprotein cholesterol (HDL-C) and adiponectin were measured. Insulin resistance was estimated by the homeostasis model assessment of insulin resistance index (HOMA-IR). There were significant differences in metabolic parameters among the groups, including waist circumference, insulin, HOMA-IR, and apo B/A-1 ratio, which increased sequentially with glucose intolerance, whereas adiponectin level decreased with increasing severity of glucose intolerance. The apo B/A-1 ratio was significantly correlated with TC, triglycerides, LDL-C, HDL-C, adiponectin, and HOMA-IR in normal glucose tolerance, impaired fasting glucose, and type 2 diabetes mellitus. Multiple regression analysis showed that apo B/A-1 ratio was significantly associated with TC, LDL-C, HDL-C, and adiponectin. In conclusion, apo B/A-1 ratio was significantly associated with insulin resistance according to glucose intolerance; and serum adiponectin was an important independent factor associated with apo B/A-1 ratio in Koreans. |
Author | Roh, Jung Min Cho, Min Ho Nam, Ji Sun Lee, Yoon Bum Yoo, Jeong Seon Lee, Hyun Chul Park, Jong Suk Lee, Eun Jig Ahn, Chul Woo Kim, Kyung Rae Cha, Bong Soo Lim, Sung Kil Jee, Sun Ha |
Author_xml | – sequence: 1 fullname: Park, Jong Suk – sequence: 2 fullname: Cho, Min Ho – sequence: 3 fullname: Nam, Ji Sun – sequence: 4 fullname: Yoo, Jeong Seon – sequence: 5 fullname: Lee, Yoon Bum – sequence: 6 fullname: Roh, Jung Min – sequence: 7 fullname: Ahn, Chul Woo – sequence: 8 fullname: Jee, Sun Ha – sequence: 9 fullname: Cha, Bong Soo – sequence: 10 fullname: Lee, Eun Jig – sequence: 11 fullname: Lim, Sung Kil – sequence: 12 fullname: Kim, Kyung Rae – sequence: 13 fullname: Lee, Hyun Chul |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22752268$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19914667$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFu1DAQhi1URLeFRwDlgjhlGduxk1xAS9UCohIH6Nly7InwkrWD7QXt2-NoI5C4II3sy_fPjL65Ihc-eCTkOYUtBSpf77cHzHoI05YB9NulKH9ENlRwVncS4IJsAJisoenFJblKaQ8AbdvJJ-SS9j1tpGw35GFn3Vw6m-x85VLlvMUZy-PzdKp0SsE4ndFWv1z-Vuk5TAWfY8hY-HdVDtWuplXU2YWSrT6FiNqnp-TxqKeEz9b_mjzc3X69-VDff37_8WZ3X5um6XPd6WawyMdWDhRGHIQVrLWSI3YdWNmJsZOG8l43kjXCMgpWGKkt9sYa2xt-TV6d-5aNfhwxZXVwyeA0aY_hmFTLedc3LReFFGfSxJBSxFHN0R10PCkKahGq9moVqhahainKS-7FOuE4HND-Ta0GC_ByBXQyehqj9salPxxjrWBMdoV7e-aw-PjpMKpkHHqD1sViX9ng_rvKm386mMl5V4Z-xxOmfThGX2QrqhJToL4s11-ODz1AU4r_BgAErcU |
CitedBy_id | crossref_primary_10_3109_14017431_2011_553966 crossref_primary_10_1016_j_arteri_2011_08_003 crossref_primary_10_1210_js_2017_00339 crossref_primary_10_1186_s12944_023_01860_w crossref_primary_10_1155_2017_3818292 crossref_primary_10_3349_ymj_2012_53_1_91 crossref_primary_10_1016_j_clinbiochem_2011_08_1142 crossref_primary_10_1089_met_2020_0058 |
Cites_doi | 10.1161/01.STR.0000140629.65145.3c 10.1006/bbrc.1999.0255 10.1093/eurheartj/ehm360 10.1016/j.metabol.2008.01.031 10.2337/diabetes.54.2.534 10.1016/S0140-6736(01)07098-2 10.1210/jc.2003-031777 10.1093/eurheartj/ehi003 10.1111/j.1365-2796.2006.01643.x 10.1001/jama.285.19.2486 10.1016/S0140-6736(04)17018-9 10.1186/1743-7075-3-18 10.1161/01.ATV.20.2.538 10.1210/jc.2004-0518 10.1161/01.CIR.0000097113.11419.9E 10.1016/j.atherosclerosis.2004.11.009 10.2337/diabetes.54.3.795 10.1016/j.thromres.2003.08.004 10.1385/ENDO:25:3:215 10.1016/S0140-6736(05)67663-5 10.1172/JCI118709 10.1016/j.atherosclerosis.2004.07.019 10.1007/BF00403180 10.1001/jama.291.14.1730 10.1016/j.bbrc.2006.11.058 10.1016/S0021-9150(01)00715-8 10.1016/j.metabol.2003.12.008 10.1161/01.CIR.93.7.1331 10.1161/01.ATV.0000219611.50066.bd 10.1016/j.diabres.2008.06.018 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2010 Elsevier Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: Elsevier Inc. – notice: 2010 Elsevier Inc. – notice: 2015 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.metabol.2009.09.013 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1532-8600 |
EndPage | 682 |
ExternalDocumentID | 10_1016_j_metabol_2009_09_013 19914667 22752268 S0026049509004004 1_s2_0_S0026049509004004 |
Genre | Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GeographicLocations | Asia Korea |
GeographicLocations_xml | – name: Korea |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 0SF 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO AAYJJ ABBQC ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABXDB ACDAQ ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AEVXI AFCTW AFFNX AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q G8K GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OB0 OHT ON- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UAP UHS WUQ X7M Z5R ZGI ~G- ~KM AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG LCYCR ZA5 08R AAPBV AAUGY ABPIF IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c449t-8a4bde3f76b10feb5d527d63ee880d685f86c139a46245d210d5c6ade9cdcd9c3 |
IEDL.DBID | AIKHN |
ISSN | 0026-0495 |
IngestDate | Sat Oct 26 00:40:52 EDT 2024 Thu Sep 26 16:59:56 EDT 2024 Sat Sep 28 07:45:38 EDT 2024 Sun Oct 22 16:08:04 EDT 2023 Fri Feb 23 02:21:21 EST 2024 Tue Oct 15 22:55:51 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Apolipoprotein B Apolipoprotein A Ratio Association Endocrinology Adiponectin |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c449t-8a4bde3f76b10feb5d527d63ee880d685f86c139a46245d210d5c6ade9cdcd9c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19914667 |
PQID | 733894735 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_733894735 crossref_primary_10_1016_j_metabol_2009_09_013 pubmed_primary_19914667 pascalfrancis_primary_22752268 elsevier_sciencedirect_doi_10_1016_j_metabol_2009_09_013 elsevier_clinicalkeyesjournals_1_s2_0_S0026049509004004 |
PublicationCentury | 2000 |
PublicationDate | 2010-05-01 |
PublicationDateYYYYMMDD | 2010-05-01 |
PublicationDate_xml | – month: 05 year: 2010 text: 2010-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Metabolism, clinical and experimental |
PublicationTitleAlternate | Metabolism |
PublicationYear | 2010 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Walldius, Jungner (bib20) 2006; 259 Petrie, Ueda, Webb, Elliott, Connell (bib8) 1996; 93 Wallenfeldt, Bokemark, Wikstrand (bib23) 2004; 35 Neumeier, Sigruener, Eggenhofer (bib29) 2007; 352 Corsetti, Zareba, Moss, Sparks (bib4) 2004; 177 Schulze, Shai, Rimm, Li, Rifai, Hu (bib27) 2005; 54 Yusuf, Hawken, Ounpuu (bib22) 2005; 366 Rahmani, Raiszadeh, Allahverdin (bib5) 2002; 162 (bib1) 2001; 285 Meisinger, Loewel, Mraz, Koenig (bib19) 2005; 26 Williams, Sniderman, Sattar, D'Agostino, Wagenknecht, Haffner (bib3) 2003; 108 Yusuf, Hawken, Ounpuu (bib21) 2004; 364 Pyorala, Miettinen, Halonen, Laakso, Pyorala (bib6) 2000; 20 Steinberg, Chaker, Leaming, Johnson, Brechtel, Baron (bib9) 1996; 97 Dunajska, Milewicz, Jedrzejuk (bib25) 2004; 25 Verges, Petit, Duvillard, Dautin, Florentin, Galland (bib30) 2006; 26 Sierra-Johnson, Romero-Corral, Somers (bib10) 2007; 28 Yoon, Lee, Lee (bib18) 2008; 57 Goldstein, Scalia (bib14) 2004; 89 Baratta, Amato, Degano (bib15) 2004; 89 Pischon, Girman, Hotamisligil, Rifai, Hu, Rimm (bib26) 2004; 291 Dzielinska, Januszewicz, Wiecek (bib24) 2003; 110 Walldius, Jungner, Holme, Aastveit, Kolar, Sreiner (bib2) 2001; 358 Ng, Watts, Farvid (bib17) 2005; 54 Matsumoto, Fujita, Nakamura, Senoo, Tominaga, Ueki (bib12) 2008; 82 Smith, Al-Amri, Sniderman, Cianflone (bib28) 2006; 3 Sung, Hwang (bib11) 2005; 180 Ferrannini, Haffner, Mitchell, Stern (bib7) 1991; 34 Arita, Kihara, Ouchi (bib13) 1999; 257 Kazumi, Kawaguchi, Hirano, Yoshino (bib16) 2004; 53 Baratta (10.1016/j.metabol.2009.09.013_bib15) 2004; 89 Verges (10.1016/j.metabol.2009.09.013_bib30) 2006; 26 Sierra-Johnson (10.1016/j.metabol.2009.09.013_bib10) 2007; 28 Corsetti (10.1016/j.metabol.2009.09.013_bib4) 2004; 177 Neumeier (10.1016/j.metabol.2009.09.013_bib29) 2007; 352 Williams (10.1016/j.metabol.2009.09.013_bib3) 2003; 108 Ng (10.1016/j.metabol.2009.09.013_bib17) 2005; 54 Pischon (10.1016/j.metabol.2009.09.013_bib26) 2004; 291 Yusuf (10.1016/j.metabol.2009.09.013_bib22) 2005; 366 Smith (10.1016/j.metabol.2009.09.013_bib28) 2006; 3 Goldstein (10.1016/j.metabol.2009.09.013_bib14) 2004; 89 Kazumi (10.1016/j.metabol.2009.09.013_bib16) 2004; 53 Petrie (10.1016/j.metabol.2009.09.013_bib8) 1996; 93 Dunajska (10.1016/j.metabol.2009.09.013_bib25) 2004; 25 Walldius (10.1016/j.metabol.2009.09.013_bib2) 2001; 358 Walldius (10.1016/j.metabol.2009.09.013_bib20) 2006; 259 Sung (10.1016/j.metabol.2009.09.013_bib11) 2005; 180 Schulze (10.1016/j.metabol.2009.09.013_bib27) 2005; 54 Yusuf (10.1016/j.metabol.2009.09.013_bib21) 2004; 364 Pyorala (10.1016/j.metabol.2009.09.013_bib6) 2000; 20 Arita (10.1016/j.metabol.2009.09.013_bib13) 1999; 257 Dzielinska (10.1016/j.metabol.2009.09.013_bib24) 2003; 110 Wallenfeldt (10.1016/j.metabol.2009.09.013_bib23) 2004; 35 Steinberg (10.1016/j.metabol.2009.09.013_bib9) 1996; 97 Ferrannini (10.1016/j.metabol.2009.09.013_bib7) 1991; 34 (10.1016/j.metabol.2009.09.013_bib1) 2001; 285 Yoon (10.1016/j.metabol.2009.09.013_bib18) 2008; 57 Rahmani (10.1016/j.metabol.2009.09.013_bib5) 2002; 162 Matsumoto (10.1016/j.metabol.2009.09.013_bib12) 2008; 82 Meisinger (10.1016/j.metabol.2009.09.013_bib19) 2005; 26 |
References_xml | – volume: 25 start-page: 215 year: 2004 end-page: 221 ident: bib25 article-title: Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men publication-title: Endocrine contributor: fullname: Jedrzejuk – volume: 110 start-page: 365 year: 2003 end-page: 369 ident: bib24 article-title: Decreased plasma concentration of a novel anti-inflammatory protein—adiponectin—in hypertensive men with coronary artery disease publication-title: Thromb Res contributor: fullname: Wiecek – volume: 97 start-page: 2601 year: 1996 end-page: 2610 ident: bib9 article-title: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance publication-title: J Clin Invest contributor: fullname: Baron – volume: 358 start-page: 2026 year: 2001 end-page: 2033 ident: bib2 article-title: High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study publication-title: Lancet contributor: fullname: Sreiner – volume: 162 start-page: 381 year: 2002 end-page: 389 ident: bib5 article-title: Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects publication-title: Atherosclerosis contributor: fullname: Allahverdin – volume: 108 start-page: 2312 year: 2003 end-page: 2316 ident: bib3 article-title: Comparison of the association of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS) publication-title: Circulation contributor: fullname: Haffner – volume: 177 start-page: 367 year: 2004 end-page: 373 ident: bib4 article-title: Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome publication-title: Atherosclerosis contributor: fullname: Sparks – volume: 93 start-page: 1331 year: 1996 end-page: 1333 ident: bib8 article-title: Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease publication-title: Circulation contributor: fullname: Connell – volume: 259 start-page: 493 year: 2006 end-page: 519 ident: bib20 article-title: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—a review of the evidence publication-title: J Intern Med contributor: fullname: Jungner – volume: 364 start-page: 937 year: 2004 end-page: 952 ident: bib21 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet contributor: fullname: Ounpuu – volume: 26 start-page: 1364 year: 2006 end-page: 1369 ident: bib30 article-title: Adiponectin is an important determinant of apoA-I catabolism publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Galland – volume: 35 start-page: 2248 year: 2004 end-page: 2252 ident: bib23 article-title: Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3-years of follow-up in middle aged men publication-title: Stroke contributor: fullname: Wikstrand – volume: 257 start-page: 79 year: 1999 end-page: 83 ident: bib13 article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity publication-title: Biochem Biophys Res Commun contributor: fullname: Ouchi – volume: 89 start-page: 2665 year: 2004 end-page: 2671 ident: bib15 article-title: Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies publication-title: J Clin Endocrinol Metab contributor: fullname: Degano – volume: 285 start-page: 2486 year: 2001 end-page: 2497 ident: bib1 article-title: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) publication-title: JAMA – volume: 89 start-page: 2563 year: 2004 end-page: 2568 ident: bib14 article-title: Adiponectin: a novel adipokine linking adipocytes and vascular function publication-title: J Clin Endocrinol Metab contributor: fullname: Scalia – volume: 54 start-page: 795 year: 2005 end-page: 802 ident: bib17 article-title: Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics publication-title: Diabetes contributor: fullname: Farvid – volume: 53 start-page: 589 year: 2004 end-page: 593 ident: bib16 article-title: Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men publication-title: Metabolism contributor: fullname: Yoshino – volume: 54 start-page: 534 year: 2005 end-page: 539 ident: bib27 article-title: Adiponectin and future coronary heart disease events among men with type 2 diabetes publication-title: Diabetes contributor: fullname: Hu – volume: 3 start-page: 18 year: 2006 end-page: 26 ident: bib28 article-title: Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women publication-title: Nutr Metab (Lond) contributor: fullname: Cianflone – volume: 34 start-page: 416 year: 1991 end-page: 422 ident: bib7 article-title: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome publication-title: Diabetologia contributor: fullname: Stern – volume: 366 start-page: 1640 year: 2005 end-page: 1649 ident: bib22 article-title: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study publication-title: Lancet contributor: fullname: Ounpuu – volume: 180 start-page: 161 year: 2005 end-page: 169 ident: bib11 article-title: Association between insulin resistance and apolipoprotein B in normoglycemic Koreans publication-title: Atherosclerosis contributor: fullname: Hwang – volume: 20 start-page: 538 year: 2000 end-page: 544 ident: bib6 article-title: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Pyorala – volume: 57 start-page: 853 year: 2008 end-page: 857 ident: bib18 article-title: The association between adiponectin and diabetes in the Korean population publication-title: Metabolism contributor: fullname: Lee – volume: 82 start-page: 93 year: 2008 end-page: 97 ident: bib12 article-title: Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus publication-title: Diabetes Res Clin Pract contributor: fullname: Ueki – volume: 26 start-page: 271 year: 2005 end-page: 278 ident: bib19 article-title: Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study publication-title: Eur Heart J contributor: fullname: Koenig – volume: 28 start-page: 2637 year: 2007 end-page: 2643 ident: bib10 article-title: ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects publication-title: Eur Heart J contributor: fullname: Somers – volume: 352 start-page: 543 year: 2007 end-page: 548 ident: bib29 article-title: High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes publication-title: Biochem Biophys Res Commun contributor: fullname: Eggenhofer – volume: 291 start-page: 1730 year: 2004 end-page: 1737 ident: bib26 article-title: Plasma adiponectin levels and risk of myocardial infarction in men publication-title: JAMA contributor: fullname: Rimm – volume: 35 start-page: 2248 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib23 article-title: Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3-years of follow-up in middle aged men publication-title: Stroke doi: 10.1161/01.STR.0000140629.65145.3c contributor: fullname: Wallenfeldt – volume: 257 start-page: 79 year: 1999 ident: 10.1016/j.metabol.2009.09.013_bib13 article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1999.0255 contributor: fullname: Arita – volume: 28 start-page: 2637 year: 2007 ident: 10.1016/j.metabol.2009.09.013_bib10 article-title: ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects publication-title: Eur Heart J doi: 10.1093/eurheartj/ehm360 contributor: fullname: Sierra-Johnson – volume: 57 start-page: 853 year: 2008 ident: 10.1016/j.metabol.2009.09.013_bib18 article-title: The association between adiponectin and diabetes in the Korean population publication-title: Metabolism doi: 10.1016/j.metabol.2008.01.031 contributor: fullname: Yoon – volume: 54 start-page: 534 year: 2005 ident: 10.1016/j.metabol.2009.09.013_bib27 article-title: Adiponectin and future coronary heart disease events among men with type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.54.2.534 contributor: fullname: Schulze – volume: 358 start-page: 2026 year: 2001 ident: 10.1016/j.metabol.2009.09.013_bib2 article-title: High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study publication-title: Lancet doi: 10.1016/S0140-6736(01)07098-2 contributor: fullname: Walldius – volume: 89 start-page: 2665 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib15 article-title: Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031777 contributor: fullname: Baratta – volume: 26 start-page: 271 year: 2005 ident: 10.1016/j.metabol.2009.09.013_bib19 article-title: Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study publication-title: Eur Heart J doi: 10.1093/eurheartj/ehi003 contributor: fullname: Meisinger – volume: 259 start-page: 493 year: 2006 ident: 10.1016/j.metabol.2009.09.013_bib20 article-title: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—a review of the evidence publication-title: J Intern Med doi: 10.1111/j.1365-2796.2006.01643.x contributor: fullname: Walldius – volume: 285 start-page: 2486 year: 2001 ident: 10.1016/j.metabol.2009.09.013_bib1 article-title: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) publication-title: JAMA doi: 10.1001/jama.285.19.2486 – volume: 364 start-page: 937 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib21 article-title: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study publication-title: Lancet doi: 10.1016/S0140-6736(04)17018-9 contributor: fullname: Yusuf – volume: 3 start-page: 18 year: 2006 ident: 10.1016/j.metabol.2009.09.013_bib28 article-title: Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women publication-title: Nutr Metab (Lond) doi: 10.1186/1743-7075-3-18 contributor: fullname: Smith – volume: 20 start-page: 538 year: 2000 ident: 10.1016/j.metabol.2009.09.013_bib6 article-title: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.2.538 contributor: fullname: Pyorala – volume: 89 start-page: 2563 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib14 article-title: Adiponectin: a novel adipokine linking adipocytes and vascular function publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-0518 contributor: fullname: Goldstein – volume: 108 start-page: 2312 year: 2003 ident: 10.1016/j.metabol.2009.09.013_bib3 article-title: Comparison of the association of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS) publication-title: Circulation doi: 10.1161/01.CIR.0000097113.11419.9E contributor: fullname: Williams – volume: 180 start-page: 161 year: 2005 ident: 10.1016/j.metabol.2009.09.013_bib11 article-title: Association between insulin resistance and apolipoprotein B in normoglycemic Koreans publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2004.11.009 contributor: fullname: Sung – volume: 54 start-page: 795 year: 2005 ident: 10.1016/j.metabol.2009.09.013_bib17 article-title: Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics publication-title: Diabetes doi: 10.2337/diabetes.54.3.795 contributor: fullname: Ng – volume: 110 start-page: 365 year: 2003 ident: 10.1016/j.metabol.2009.09.013_bib24 article-title: Decreased plasma concentration of a novel anti-inflammatory protein—adiponectin—in hypertensive men with coronary artery disease publication-title: Thromb Res doi: 10.1016/j.thromres.2003.08.004 contributor: fullname: Dzielinska – volume: 25 start-page: 215 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib25 article-title: Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men publication-title: Endocrine doi: 10.1385/ENDO:25:3:215 contributor: fullname: Dunajska – volume: 366 start-page: 1640 year: 2005 ident: 10.1016/j.metabol.2009.09.013_bib22 article-title: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study publication-title: Lancet doi: 10.1016/S0140-6736(05)67663-5 contributor: fullname: Yusuf – volume: 97 start-page: 2601 year: 1996 ident: 10.1016/j.metabol.2009.09.013_bib9 article-title: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance publication-title: J Clin Invest doi: 10.1172/JCI118709 contributor: fullname: Steinberg – volume: 177 start-page: 367 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib4 article-title: Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2004.07.019 contributor: fullname: Corsetti – volume: 34 start-page: 416 year: 1991 ident: 10.1016/j.metabol.2009.09.013_bib7 article-title: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome publication-title: Diabetologia doi: 10.1007/BF00403180 contributor: fullname: Ferrannini – volume: 291 start-page: 1730 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib26 article-title: Plasma adiponectin levels and risk of myocardial infarction in men publication-title: JAMA doi: 10.1001/jama.291.14.1730 contributor: fullname: Pischon – volume: 352 start-page: 543 year: 2007 ident: 10.1016/j.metabol.2009.09.013_bib29 article-title: High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.11.058 contributor: fullname: Neumeier – volume: 162 start-page: 381 year: 2002 ident: 10.1016/j.metabol.2009.09.013_bib5 article-title: Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects publication-title: Atherosclerosis doi: 10.1016/S0021-9150(01)00715-8 contributor: fullname: Rahmani – volume: 53 start-page: 589 year: 2004 ident: 10.1016/j.metabol.2009.09.013_bib16 article-title: Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men publication-title: Metabolism doi: 10.1016/j.metabol.2003.12.008 contributor: fullname: Kazumi – volume: 93 start-page: 1331 year: 1996 ident: 10.1016/j.metabol.2009.09.013_bib8 article-title: Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease publication-title: Circulation doi: 10.1161/01.CIR.93.7.1331 contributor: fullname: Petrie – volume: 26 start-page: 1364 year: 2006 ident: 10.1016/j.metabol.2009.09.013_bib30 article-title: Adiponectin is an important determinant of apoA-I catabolism publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000219611.50066.bd contributor: fullname: Verges – volume: 82 start-page: 93 year: 2008 ident: 10.1016/j.metabol.2009.09.013_bib12 article-title: Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2008.06.018 contributor: fullname: Matsumoto |
SSID | ssj0007786 |
Score | 2.033529 |
Snippet | Abstract Apolipoprotein B to A-1 (apo B/A-1) ratio is reportedly a better predictor of atherosclerotic vascular disease than low-density lipoprotein... Apolipoprotein B to A-1 (apo B/A-1) ratio is reportedly a better predictor of atherosclerotic vascular disease than low-density lipoprotein cholesterol... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 677 |
SubjectTerms | Adiponectin - blood Adult Aged Apolipoprotein A-I - blood Apolipoproteins B - blood Biological and medical sciences Cholesterol - blood Cross-Sectional Studies Endocrinology & Metabolism Feeding. Feeding behavior Fundamental and applied biological sciences. Psychology Glucose Intolerance Humans Insulin Resistance Korea Linear Models Middle Aged Multivariate Analysis Triglycerides - blood Vertebrates: anatomy and physiology, studies on body, several organs or systems |
Title | Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0026049509004004 https://dx.doi.org/10.1016/j.metabol.2009.09.013 https://www.ncbi.nlm.nih.gov/pubmed/19914667 https://search.proquest.com/docview/733894735 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7yoKVQQpu-3KaLDr161w9Zso7b0LBJaE5dyE3IeoBDapvaOeTS396RLW8IJRQKPhkLj2dGM99Y8wD4UhhH09SImCk_wkzzPFa6EHGlS1eVKlfUjQmyV2yzpRfXxfUenM61MD6tMtj-yaaP1jrcWQVurrq69jW-iMUR3ydi0sR9OER3lKFqH67PLzdXO4PsW6RNmR4YPOOCh0Ke1c3ypx2Q27ehcyVeaf6Ui3rZqR4Z56aJF09D0tE1nb2Co4ApyXoi-zXs2eYYnk1TJu-P4fn3cH7-BrZrU3dt441cQ-qe1LshuMPtPVFBVNYQ_3uWKD_BoWvHVg74_FcytGQdp2RUGlxLLluEnE3_FrZn336cbuIwWCHWlIohLhWtjM0dZ1WaOFsVpsi4Ybm1uJsNKwtXMo3QUFGW0cJgVGgKzZSxQhtthM7fwUGDxH4AwnWiEFOaXDhOFaqDw4BFVay0PGNGZREsZ17KbuqfIefEshsZmO9nYQrprzSPgM8cl3NxKJoz24e91ctU9plM5F_yj6DcrXykQhK9w79eungk2x2pWcY9QC0jILOwJe4_f6iiGtve9ZJjjC_8_OYI3k9K8PCdiL0pY_zj_xP2CV7M6QpJegIHw687-xlR0FAtYH_5O10EXf8DzkIG6g |
link.rule.ids | 315,783,787,4510,24129,27937,27938,45598,45692 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja90wEB7SlC5QSptu7pLq0Kvf8yJL1vE1NLw2yykPchOyFnBIbVM7h1z62zuy5fcIJRQKOhkJj2dGo2-sWQC-FMbRNDUiZsq3MNM8j5UuRFzp0lWlyhV1Y4DsOVtv6I_L4nIPjuZcGB9WGWz_ZNNHax2eLAM3l11d-xxfxOKI7xMxaeIDeEh9uXFU6sXvXZyHL5A2xXmg64zTd2k8y6vFTzsgr69D3UocaX7fAfWsUz2yzU39Lu4HpOPBdPwCngdESVYT0S9hzzYH8GjqMXl7AI_Pwu35K9isTN21jTdxDal7Um9b4A7Xt0QFQVlD_M9Zonz_hq4dCzng_K9kaMkqTsmoMriWnLQIOJv-NWyOv10crePQViHWlIohLhWtjM0dZ1WaOFsVpsi4Ybm1uJcNKwtXMo3AUFGW0cKgT2gKzZSxQhtthM7fwH6DxL4DwnWiEFGaXDhOFSqDQ3dFVay0PGNGZREsZl7KbqqeIeewsisZmO87YQrpR5pHwGeOyzk1FI2Z7cPO6mUq-0wm8i_pR1BuV95RIIlnw79eenhHtltSs4x7eFpGQGZhS9x9_kpFNba96SVHD1_47s0RvJ2UYPediLwpY_z9_xP2GZ6sL85O5en385MP8HQOXEjSj7A__LqxnxAPDdXhqO9_ADORB8M |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adiponectin+is+independently+associated+with+apolipoprotein+B+to+A-1+ratio+in+Koreans&rft.jtitle=Metabolism%2C+clinical+and+experimental&rft.au=Park%2C+Jong+Suk&rft.au=Cho%2C+Min+Ho&rft.au=Nam%2C+Ji+Sun&rft.au=Yoo%2C+Jeong+Seon&rft.date=2010-05-01&rft.pub=Elsevier+Inc&rft.issn=0026-0495&rft.eissn=1532-8600&rft.volume=59&rft.issue=5&rft.spage=677&rft.epage=682&rft_id=info:doi/10.1016%2Fj.metabol.2009.09.013&rft.externalDocID=S0026049509004004 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00260495%2FS0026049510X0004X%2Fcov150h.gif |